Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash from Financing Activities (2016 - 2025)

AtriCure (ATRC) has disclosed Cash from Financing Activities for 16 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 20.71% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 132.64% increase, with the full-year FY2025 number at $1.2 million, up 132.64% from a year prior.
  • Cash from Financing Activities was $2.1 million for Q4 2025 at AtriCure, down from $6.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $6.0 million in Q3 2025 to a low of -$10.7 million in Q1 2021.
  • A 5-year average of -$858000.0 and a median of $1.8 million in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: plummeted 650.83% in 2021, then soared 1897.0% in 2025.
  • AtriCure's Cash from Financing Activities stood at $2.5 million in 2021, then dropped by 20.94% to $2.0 million in 2022, then increased by 19.02% to $2.4 million in 2023, then fell by 26.32% to $1.7 million in 2024, then grew by 20.71% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Cash from Financing Activities are $2.1 million (Q4 2025), $6.0 million (Q3 2025), and $3.4 million (Q2 2025).